137 related articles for article (PubMed ID: 31125042)
1. Evolving Issues in the Treatment of Depression.
Köhler-Forsberg O; Cusin C; Nierenberg AA
JAMA; 2019 Jun; 321(24):2401-2402. PubMed ID: 31125042
[No Abstract] [Full Text] [Related]
2. Ketamine for treatment-resistant depression: ready or not for clinical use?
Rush AJ
Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324
[No Abstract] [Full Text] [Related]
3. Speed of response to electroconvulsive therapy compared with ketamine.
Kellner CH; ; Lisanby SH; Weiner R; Prudic J; Rudorfer MV; Young RC; Petrides G; McCall WV; Husain M; Greenberg RM; Knapp RG
Psychiatry Res; 2015 Jan; 225(1-2):215. PubMed ID: 25511506
[No Abstract] [Full Text] [Related]
4. Comparison of ketamine vs. ECT in major depressive disorder: need for ECT standard dosing and duration parameters.
Campion P
Psychiatry Res; 2015 Jan; 225(1-2):216. PubMed ID: 25511507
[No Abstract] [Full Text] [Related]
5. A word to the wise about ketamine.
Schatzberg AF
Am J Psychiatry; 2014 Mar; 171(3):262-4. PubMed ID: 24585328
[No Abstract] [Full Text] [Related]
6. Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report.
Gálvez V; O'Keefe E; Cotiga L; Leyden J; Harper S; Glue P; Mitchell PB; Somogyi AA; DeLory A; Loo CK
Biol Psychiatry; 2014 Aug; 76(3):e1-2. PubMed ID: 24507509
[No Abstract] [Full Text] [Related]
7. Electroconvulsive therapy is a standard treatment; ketamine is not (yet).
Kellner CH; Greenberg RM; Ahle GM; Liebman LS
Am J Psychiatry; 2014 Jul; 171(7):796. PubMed ID: 24980176
[No Abstract] [Full Text] [Related]
8. Response to Zhang and Ho: Addressing Ketamine's Use in Depression.
Newport DJ; Nemeroff CB
Am J Psychiatry; 2016 Apr; 173(4):431-2. PubMed ID: 27035536
[No Abstract] [Full Text] [Related]
9. Critical Appraisal of Existing Ketamine Trials: Existing Limitations and Limited Applicability for Treatment.
Zhang MW; Ho R
Am J Psychiatry; 2016 Apr; 173(4):431. PubMed ID: 27035535
[No Abstract] [Full Text] [Related]
10. Ketamine as an alternative treatment for treatment-resistant depression.
Dowben JS; Grant JS; Keltner NL
Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
[No Abstract] [Full Text] [Related]
11. [Ketamine for treatment of depression?].
Vinberg M
Ugeskr Laeger; 2013 Sep; 175(37):2089. PubMed ID: 24011202
[No Abstract] [Full Text] [Related]
12. Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder.
Blier P
Biol Psychiatry; 2013 Aug; 74(4):238-9. PubMed ID: 23885752
[No Abstract] [Full Text] [Related]
13. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
[TBL] [Abstract][Full Text] [Related]
14. Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy.
Goforth HW; Holsinger T
J ECT; 2007 Mar; 23(1):23-5. PubMed ID: 17435569
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.
Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS
Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146
[TBL] [Abstract][Full Text] [Related]
16. Ketamine for Treatment-Resistant Depression: a New Advocate.
Pérez-Esparza R
Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
[TBL] [Abstract][Full Text] [Related]
17. Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.
Owen RT
Drugs Today (Barc); 2012 Jul; 48(7):469-78. PubMed ID: 22844658
[TBL] [Abstract][Full Text] [Related]
18. Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases.
Paul R; Schaaff N; Padberg F; Möller HJ; Frodl T
World J Biol Psychiatry; 2009; 10(3):241-4. PubMed ID: 19224412
[TBL] [Abstract][Full Text] [Related]
19. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
Newport DJ; Carpenter LL; McDonald WM; Potash JB; Tohen M; Nemeroff CB;
Am J Psychiatry; 2015 Oct; 172(10):950-66. PubMed ID: 26423481
[TBL] [Abstract][Full Text] [Related]
20. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
